INT DIABETES INST has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and it methods for management are S & T GLOBAL INC, IMMURON LTD and Lateral IP Pty Ltd.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | New Zealand | 2 | |
#6 | Canada | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | IT methods for management |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Data processing systems |
# | Name | Total Patents |
---|---|---|
#1 | Zimmet Paul Zev | 15 |
#2 | Collier Gregory | 9 |
#3 | Westerman Roderick Alan | 4 |
#4 | Ng Frank Man-Woon | 3 |
#5 | Collier Georges | 2 |
#6 | Layton Gary John | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006084303A1 | Glycemic and health-related data management | |
AUPR595601A0 | Hypoglycaemic peptides and methods of use thereof | |
AU1011299A | A novel gene and uses therefor | |
EP1030915A1 | A novel gene and uses therefor | |
AUPP032397A0 | A novel gene and uses therefor-II | |
AUPP011797A0 | A novel gene and uses therefor | |
AU3429697A | Treatment of obesity | |
AUPO108596A0 | Treatment of obesity |